Exploring the potential of xanthene derivatives as trypanothione reductase inhibitors and chloroquine potentiating agents
- 1 March 2003
- journal article
- Published by Elsevier BV in Tetrahedron
- Vol. 59 (13), 2289-2296
- https://doi.org/10.1016/s0040-4020(03)00240-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitorsStructure, 1999
- Phenothiazine Inhibitors of Trypanothione Reductase as Potential Antitrypanosomal and Antileishmanial DrugsJournal of Medicinal Chemistry, 1998
- Rational design of selective ligands for trypanothione reductase fromtrypanosoma cruzStructural effects on the inhibition by dibenzazepines based on imipramineJournal of Enzyme Inhibition, 1997
- An Improved Catalyst System for Aromatic Carbon−Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key IntermediatesJournal of the American Chemical Society, 1996
- Synthesis and Conformational Preferences of a Potential β-Sheet Nucleator Based on the 9,9-Dimethylxanthene SkeletonThe Journal of Organic Chemistry, 1996
- Site-Directed Mutagenesis of the Redox-Active Cysteines of Trypanosoma cruzi Trypanothione ReductaseJBIC Journal of Biological Inorganic Chemistry, 1995
- Selective antimalarial activity of tetrandrine against chloroquine resistant plasmodium falciparumBiochemical and Biophysical Research Communications, 1989
- Reversal of Chloroquine Resistance in Malaria Parasite Plasmodium falciparum by DesipramineScience, 1988
- Trypanothione: A Novel Bis(glutathionyl)spermidine Cofactor for Glutathione Reductase in TrypanosomatidsScience, 1985
- Plasmodium falciparum in Owl Monkeys: Drug Resistance and Chloroquine Binding CapacityScience, 1970